Oral Microbiome Linked to COVID-19 Diagnosis

NEW YORK (Reuters Health) – Oral microbial markers may be a potential diagnostic tool for COVID-19, researchers suggest. As reported in Gut, Dr. Lanjuan Li of Zhengzhou University in China and colleagues sequenced 392 tongue-coating samples, 172 fecal and 155 serum samples from Central and East China. They characterized the microbiome and lipid molecules, then constructed microbial classifiers in a […]

Read more

Black Americans Underrepresented in Clinical Trials of Cardiovascular Drugs

NEW YORK (Reuters Health) – Black U.S. residents have been significantly underrepresented in pivotal clinical trials of 24 cardiovascular drugs that received Food and Drug Administration (FDA) approval during the last 15 years, according to two researchers in China. The underrepresentation could undermine the generalizability of the trials and the use of new cardiovascular drugs in Black Americans, they write […]

Read more